Ivana Magovcevic-Liebisch - 08 Feb 2024 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Issuer symbol
ACRV
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
3
Filing time
09 Feb 2024, 16:34:30 UTC
Previous filing
20 Nov 2023
Next filing
01 Mar 2024

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney